Infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal cancer (MCRC): Results of the safety and efficacy analysis

H.-T. Arkenau; H. Schmoll; S. Kubicka; A. Kretzschmar; W. Freier; T. Seufferlein; U. Graeven; A. Grothey; A. Hinke; R. Porschen

doi:10.1200/jco.2005.23.16_suppl.3507

Infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal cancer (MCRC): Results of the safety and efficacy analysis

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.3507 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 3507-3507 ◽

Cited By ~ 14

Author(s):

H.-T. Arkenau ◽

H. Schmoll ◽

S. Kubicka ◽

A. Kretzschmar ◽

W. Freier ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Folinic Acid ◽

Line Treatment ◽

First Line ◽

Safety And Efficacy ◽

Efficacy Analysis ◽

First Line Treatment

Download Full-text

Safety and efficacy of FOLFOXIRI with or without targeted agents as first-line treatment of selected elderly metastatic colorectal cancer patients: a pooled analysis of GONO studies

Annals of Oncology ◽

10.1093/annonc/mdw335.14 ◽

2016 ◽

Vol 27 ◽

pp. iv43

Author(s):

D. Rossini ◽

M. Casagrande ◽

R. Moretto ◽

F. Loupakis ◽

C. Cremolini ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Pooled Analysis ◽

Line Treatment ◽

Targeted Agents ◽

First Line ◽

Safety And Efficacy ◽

Colorectal Cancer Patients ◽

First Line Treatment

Download Full-text

Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015

Annals of Oncology ◽

10.1093/annonc/mdm544 ◽

2008 ◽

Vol 19 (5) ◽

pp. 920-926 ◽

Cited By ~ 103

Author(s):

C.-H. Köhne ◽

J. De Greve ◽

J.T. Hartmann ◽

I. Lang ◽

P. Vergauwe ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Folinic Acid ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text

Palliative first-line treatment with weekly high-dose 5-fluorouracil (5-FU) and sodium folinic acid (s-FA) (AIO-schedule) as 24h-infusion plus biweekly oxaliplatin (ox) in patients with definitively nonresectable metastatic colorectal cancer (CRC) following secondary (sec) metastatic resection: An interdisciplinary phase II trial

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.15064 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 15064-15064

Author(s):

H. Albrecht ◽

A. Wein ◽

K. Wolff ◽

V. Brueckl ◽

C. Meier ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Folinic Acid ◽

Phase Ii ◽

Phase Ii Trial ◽

High Dose ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text

Palliative first-line treatment with weekly high-dose 5-fluorouracil and sodium folinic acid (s-FA) (AIO-schedule) as 24h-infusion plus bi-weekly oxaliplatin (ox) in patients with definitively non-resectable metastatic colorectal cancer (CRC) following secondary (s.) metastatic resection: An interdisciplinary phase II-Trial

Zeitschrift für Gastroenterologie ◽

10.1055/s-0028-1089593 ◽

2008 ◽

Vol 46 (09) ◽

Author(s):

H Albrecht ◽

A Wein ◽

C Meier ◽

N Ostermeier ◽

V Brueckl ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Folinic Acid ◽

Phase Ii ◽

Phase Ii Trial ◽

High Dose ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text

Phase III trial of irinotecan plus oxaliplatin (IROX) versus irinotecan plus 5-FU/folinic acid (FOLFIRI) as first-line treatment of metastatic colorectal cancer (CRC): The FIRE-Trial

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.3516 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 3516-3516 ◽

Cited By ~ 7

Author(s):

A. Schalhorn ◽

F. W. Ludwig ◽

D. Quietzsch ◽

P. A. Maubach ◽

G. Schlimok ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Folinic Acid ◽

Phase Iii ◽

Line Treatment ◽

First Line ◽

Phase Iii Trial ◽

First Line Treatment

Download Full-text

Safety and efficacy of bevacizumab (Bev) when added to oxaliplatin/fluoropyrimidine (O/F) regimens as first-line treatment of metastatic colorectal cancer (mCRC): TREE 1 & 2 Studies

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.3515 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 3515-3515 ◽

Cited By ~ 26

Author(s):

H. S. Hochster ◽

L. Welles ◽

L. Hart ◽

R. K. Ramanathan ◽

J. Hainsworth ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Line Treatment ◽

First Line ◽

Safety And Efficacy ◽

First Line Treatment

Download Full-text

P-35 HGCSG1901: A retrospective cohort study evaluating the safety and efficacy of S-1 and irinotecan plus bevacizumab in patients with metastatic colorectal cancer: Analysis of first-line treatment

Annals of Oncology ◽

10.1016/j.annonc.2021.05.090 ◽

2021 ◽

Vol 32 ◽

pp. S108

Author(s):

K. Ito ◽

S. Yuki ◽

S. Nakano ◽

M. Yagisawa ◽

K. Sawada ◽

...

Keyword(s):

Colorectal Cancer ◽

Cohort Study ◽

Metastatic Colorectal Cancer ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

Line Treatment ◽

First Line ◽

Safety And Efficacy ◽

First Line Treatment

Download Full-text

104P Safety and efficacy of HLX04 versus reference bevacizumab in combination with XELOX or mFOLFOX6 as first-line treatment for metastatic colorectal cancer: A randomised, double-blind phase III study

Annals of Oncology ◽

10.1016/j.annonc.2020.10.124 ◽

2020 ◽

Vol 31 ◽

pp. S1282

Author(s):

S. Qin ◽

J. Li ◽

Y. Bai ◽

Y. Shu ◽

W. Li ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Iii ◽

Line Treatment ◽

First Line ◽

Double Blind ◽

Safety And Efficacy ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study

Annals of Oncology ◽

10.1093/annonc/mdw176 ◽

2016 ◽

Vol 27 (7) ◽

pp. 1273-1279 ◽

Cited By ~ 40

Author(s):

G. Folprecht ◽

C. Pericay ◽

M.P. Saunders ◽

A. Thomas ◽

R. Lopez Lopez ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Folinic Acid ◽

Line Treatment ◽

First Line ◽

Modified Folfox6 ◽

First Line Treatment

Download Full-text

FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG)

British Journal of Cancer ◽

10.1038/sj.bjc.6603011 ◽

2006 ◽

Vol 94 (6) ◽

pp. 798-805 ◽

Cited By ~ 236

Author(s):

J Souglakos ◽

N Androulakis ◽

K Syrigos ◽

A Polyzos ◽

N Ziras ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Folinic Acid ◽

Research Group ◽

Phase Iii ◽

Line Treatment ◽

First Line ◽

Phase Iii Trial ◽

Oncology Research ◽

First Line Treatment

Download Full-text